Stocks With The Highest
Upside Forecast

Based on 25,000+ 1-year price targets provided by
5,000+ Wall Street analysts over the past 3-months

Name Upside % Analysts
bullish %
VKTX icon
1
Viking Therapeutics
VKTX
$2.71B
263%
upside
3 price targets
0
RARE icon
2
Ultragenyx Pharmaceutical
RARE
$2.79B
162%
upside
7 price targets
0
LEGN icon
3
Legend Biotech
LEGN
$6.25B
113%
upside
6 price targets
0
ARWR icon
4
Arrowhead Research
ARWR
$3.96B
107%
upside
3 price targets
0
IMVT icon
5
Immunovant
IMVT
$2.71B
93%
upside
4 price targets
0
IDYA icon
6
IDEAYA Biosciences
IDYA
$2.15B
92%
upside
7 price targets
0
CLSK icon
7
CleanSpark
CLSK
$2.89B
92%
upside
6 price targets
0
MTSR
8
Metsera, Inc. Common Stock
MTSR
$3.59B
87%
upside
3 price targets
0
CRGY icon
9
Crescent Energy
CRGY
$2.14B
81%
upside
4 price targets
0
RNA icon
10
Avidity Biosciences
RNA
$5.17B
75%
upside
9 price targets
0
CGON icon
11
CG Oncology
CGON
$2.64B
75%
upside
6 price targets
0
FRSH icon
12
Freshworks
FRSH
$3.66B
74%
upside
5 price targets
0
RVMD icon
13
Revolution Medicines
RVMD
$8.64B
64%
upside
10 price targets
0
IRON icon
14
Disc Medicine
IRON
$2.08B
64%
upside
3 price targets
0
CYTK icon
15
Cytokinetics
CYTK
$5.92B
62%
upside
6 price targets
0
ALKS icon
16
Alkermes
ALKS
$4.38B
60%
upside
7 price targets
0
PRMB
17
Primo Brands Corporation
PRMB
$8.38B
59%
upside
6 price targets
0
ACLX icon
18
Arcellx
ACLX
$4.17B
59%
upside
3 price targets
0
NAMS icon
19
NewAmsterdam Pharma
NAMS
$2.72B
59%
upside
4 price targets
0
MARA icon
20
Marathon Digital Holdings
MARA
$6.02B
57%
upside
7 price targets
0
DV icon
21
DoubleVerify
DV
$2.13B
54%
upside
6 price targets
0
ETOR
22
eToro Group Ltd. Class A Common Shares
ETOR
$3.63B
53%
upside
7 price targets
0
RELY icon
23
Remitly
RELY
$3.44B
52%
upside
3 price targets
0
WING icon
24
Wingstop
WING
$7.47B
51%
upside
12 price targets
0
BRZE icon
25
Braze
BRZE
$3.38B
51%
upside
11 price targets
0